Blog

On Sept. 13, 2019, the U.S. Food and Drug Administration’s (FDA) Allergenic Products Advisory Committee recommended the approval of Aimmune Therapeutics’ peanut treatment, Palforzia. If approved, Palforzia would be ground-breaking for the future of food allergy treatments. What Is Palforzia? Palforzia, also known as AR101, is a type of oral immunotherapy (OIT) for peanut allergy. If approved, it would be the first FDA-approved treatment for peanut allergy. Currently, some allergists already...

Our report – the My Life With Food Allergy: Parent Survey Report – gives a summary of the emotional, social and financial impact on the parent or caregiver of a child with food allergies. Read more about the findings.

The manufacturers of epinephrine auto-injectors have extended their U.S. savings card programs through 2018. Epinephrine is the only treatment for a severe allergic reaction known as anaphylaxis (anna-fih-LACK-sis). It is only available through a prescription by your doctor. Each prescription comes with two auto-injectors in a set. People with food allergies need two of these auto-injectors with them at all times.

The Asthma and Allergy Foundation of America (AAFA) addresses concerns regarding the Final Evidence Report assessing the clinical effectiveness and value of treatments for peanut allergy released by the Institute for Clinical and Economic Review (ICER) on July 10, 2019. ICER’s report may cause concern for the allergy community that the findings will restrict access to new treatments for peanut allergy.

The Asthma and Allergy Foundation of America (AAFA) is asking Congress to support the School-Based Allergies and Asthma Management Program Act (H.R. 2468). If passed, this bill would put important protections in place for children with allergies and asthma. Kids With Food Allergies (KFA) is a division of AAFA.

As supply interruptions and shortages of epinephrine auto-injectors continue, the FDA has extended the expiration dates of all lots of EpiPen® (epinephrine injection, USP) 0.3 mg Auto-Injectors and its authorized generic version currently on the market in the U.S. after a review of stability data. Read more for the new expiration dates.

Each May since 1984, the Asthma and Allergy Foundation of America (AAFA) has declared May to be National Asthma and Allergy Awareness Month. This month is dedicated to teaching others about asthma and allergies to create more awareness and understanding. Kids With Food Allergies (KFA) is a division of AAFA. May 12-18, 2019, is also Food Allergy Awareness Week. During this week, we focus on spreading information about what it’s like to manage food allergies and raise awareness about anaphylaxis,

It is World Allergy Week and this year’s theme is The Global Problem of Food Allergy. To help us take action on food allergies, we are seeking 1,000 individuals to fill out a survey that may take 15-30 minutes to complete (the length of the survey depends on your answers).

The Asthma and Allergy Foundation of America (AAFA) has released the 2019 Spring Allergy Capitals™ report ranking the top 100 most challenging cities in the U.S. for spring allergies. Kids With Food Allergies (KFA) is a division of AAFA.

Updated for 2019, the Kids With Food Allergies’ Easter candy guide is filled with food allergy-friendly sweets. Even favorites such as chocolate bunnies and jelly beans are included. Please remember to read all labels and make sure the product is right for your family.

FDA is alerting patients, caregivers and health care professionals that the labels attached to some EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions, may block access to the auto-injector and prevent the ability to easily access the product.

Sesame allergy ranks ninth in prevalence behind the top 8 allergens. But manufacturers are not required to clearly label sesame on their products. It can even go unlabeled under terms like “spices” and “natural flavoring.” This is very distressing as reactions to sesame can be among the most severe for adults and children. We are asking community members who have had an adverse reaction to sesame, or care for someone who has, to share their story with the FDA.